mTOR Enzyme May be Target for Preventing Diabetic Kidney Disease

Researchers from the University of Freiberg in Germany have identified a metabolic enzyme called mTOR as a target for preventing diabetic kidney disease. They showed that while mTOR is important to early glomerular development, it becomes overactive in diabetics, causing damage to the filtering units of the kidney. Using a mouse model, the scientists inhibited mTOR activation genetically to stop the progression of kidney damage. The discovery may one day result in a viable therapy for diabetic nephropathy and other glomerular diseases.


When Sugar Damages Kidneys: New Hope for Diabetes Patients with Kidney Disease, University of Freiberg, June 15, 2011

Share Button

One Comment

  1. This is a great news for diabetics. But more research should be done to stop mtor from being overactive especially in diabetics to prevent kidney damage and hopefully someday we will find a treatment/therapy for different diseases using this method.

    langhorne pa orthopedics

Leave a Reply

Your email address will not be published. Required fields are marked *